Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Becton, Dickinson And Co.
Nieuws
Becton, Dickinson And Co.
BDX
NYS
: BDX
| ISIN: US0758871091
15/10/2026
193,76 USD
(+2,58%)
(+2,58%)
15/10/2026
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
8 oktober 2026 ·
BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2026
· Persbericht
8 oktober 2026 ·
BD and Global Health Leaders Call for Accelerated Maternal Life Saving Measures Worldwide
· Persbericht
7 oktober 2026 ·
BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results
· Persbericht
6 oktober 2026 ·
BD Celebrates 65 Years of Manufacturing, Innovation and Community Partnership in Canaan
· Persbericht
6 oktober 2026 ·
BD Appoints Ferass Abuzaina as Worldwide President of Surgery
· Persbericht
6 oktober 2026 ·
BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America's Healthcare Resilience
· Persbericht
29 september 2026 ·
BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
· Persbericht
21 september 2026 ·
Arthur Hu to Join BD as Chief Information and Digital Officer
· Persbericht
14 september 2026 ·
BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview
· Persbericht
27 augustus 2026 ·
BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
· Persbericht
26 augustus 2026 ·
BD to Present at Wells Fargo 21st Annual Healthcare Conference
· Persbericht
17 augustus 2026 ·
BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire
· Persbericht
12 augustus 2026 ·
BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
· Persbericht
6 augustus 2026 ·
BD Reports Third Quarter Fiscal 2026 Financial Results
· Persbericht
29 juli 2026 ·
EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
· Persbericht
28 juli 2026 ·
BD Board Declares Dividend
· Persbericht
22 juli 2026 ·
Mike Garrison to Retire from BD
· Persbericht
9 juli 2026 ·
BD to Announce Financial Results for its Third Quarter of Fiscal 2026
· Persbericht
23 juni 2026 ·
BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System
· Persbericht
21 mei 2026 ·
BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe